Organization · Accelerator
IndieBio
IndieBio is a leading biotech accelerator under SOSV, focusing on early-stage startups in biotechnology and deep tech. It provides unique access to wet lab infrastructure and significant funding to support innovative solutions for human and planetary health.
Overview
What IndieBio does
What IndieBio is
IndieBio is a leading biotech accelerator under SOSV, focusing on early-stage startups in biotechnology and deep tech. It provides unique access to wet lab infrastructure and significant funding to support innovative solutions for human and planetary health.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- March 27, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find IndieBio elsewhere
Open the official website or a supported primary organization account.
Capability profile
IndieBio as a funder
Investment thesis
IndieBio invests in early-stage biotech startups that address human and planetary health challenges, leveraging biology to create innovative solutions across various sectors.
Focus narrative
IndieBio invests in a diverse range of sectors where biology can drive innovation, including climate tech, food, therapeutics, and materials. The accelerator supports startups primarily at the pre-seed stage and continues to provide follow-on investments, fostering a robust ecosystem for biotech entrepreneurs.
Value beyond capital
IndieBio provides significant value to its portfolio companies through access to BSL-2 wet lab facilities, scientific mentorship, business development support, and a global network of over 1,000 portfolio companies. This infrastructure and support system is designed to accelerate the growth and success of biotech startups.
Terms and economics
- Typical check
- $250,000–$525,000
- Sweet spot
- $250,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Sectors
- Biotech · Climate · Food and AgTech · Healthcare · Energy · Materials Science
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 270
- Recorded notable exits
- NotCo, UPSIDE Foods, and MycoWorks
Portfolio context
IndieBio has funded over 270 companies globally, with notable portfolio companies such as: Zymochem: Develops sustainable materials using patented Carbon-Conserving (C2) microbes. Avalo.ai: A gene discovery platform for breeding climate-resilient crops. Ten63 Therapeutics: Focuses on in silico drug design. Hoofprint Biome: Works on solutions to reduce methane emissions from cattle. Calder Biosciences: Develops next-generation vaccines.
Capability profile
IndieBio as a program host
Program thesis
IndieBio is a program of SOSV that supports innovative ideas in biotechnology, focusing on early-stage biotech startups addressing human and planetary health challenges.
Focus narrative
IndieBio invests in a diverse range of sectors where biology can create innovative solutions, including climate tech, food, therapeutics, and materials. The organization emphasizes diversity within its portfolio, particularly supporting female founders and companies that address pressing global issues.
Value and support
IndieBio offers hands-on lab access, scientific mentorship, business development support, and access to a global network of over 1,000 portfolio companies. The program is designed to provide both capital and critical infrastructure for biotech founders.
Additional public guidance
Q: What is the duration of the program? A: The program lasts approximately 4 months. Q: How many cohorts are there each year? A: IndieBio runs 2 cohorts per year. Q: What is the initial investment amount? A: The initial investment is $250K for 6-8% equity.
Terms and economics
- Indicative investment
- $250,000
- Indicative equity
- 6%
Format and cadence
- Typical duration
- 16 weeks
- Typical cohort
- 15 companies
- Cohorts per year
- 2
- Format
- In Person
Availability
- Application state
- Accepting
Focus and fit
- Stages
- Accelerator · Pre-seed · Seed
- Regions
- Global · North America
Alumni and track record
Alumni context
Notable alumni companies include Zymochem, which develops sustainable materials; Avalo.ai, a gene discovery platform for climate-resilient crops; Ten63 Therapeutics, focusing on in silico drug design; Hoofprint Biome, which mitigates methane emissions from cattle; and Calder Biosciences, developing next-generation vaccines.
Common questions
What to know about IndieBio
Upseed classifies IndieBio under the Accelerator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.